DJIA 16,614.81 215.14 1.31%
NASDAQ 4,419.48 103.40 2.40%
S&P 500 1,941.28 37.27 1.96%
market minute promo

159.35 6.96 (4.57%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

JAZZ $159.35 4.57%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $154.23
Previous Close $152.39
Daily Range $154.23 - $159.50
52-Week Range $84.76 - $176.60
Market Cap $9.6B
P/E Ratio 118.13
Dividend (Yield) $0.00 (0.0%)
Volume 580,163
Average Daily Volume 811,622
Current FY EPS $7.40





Jazz Pharmaceuticals, Inc. (JAZZ) Description

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Website:

News & Commentary Rss Feed

Should You Invest in Corporate Tax Inversions?

Despite the controversy regarding whether corporate inversions are right or wrong, investors are looking to make money from them. Has Motif Investing put together a way for small investors to profit from tax inversions?

Cowen’s Sell-Off Shopping List Loaded With Stocks With Huge Upside Potential

Insider Trading Alert - AYI, MDSO And JAZZ Traded By Insiders

Bullish Two Hundred Day Moving Average Cross - JAZZ

Concert Pharmaceuticals Announces Positive CTP-354 Data - Analyst Blog

Jazz Pharmaceuticals: An Attractive Play In An Attractive Industry

Zoetis Will Benefit from Industry Trends

Jazz Pharmaceuticals Uses New Cash To Buy For Growth

Top Fund Buys: Chipotle, Allergan, Jazz, Gilead

Why I Am Still Bullish On Jazz Pharmaceuticals

Shire Resolves Litigation Related to Vyvanse, Adderall XR - Analyst Blog

See More JAZZ News...

JAZZ's Top Competitors

JAZZ $159.35 (4.57%)
Current stock: JAZZ
JNJ $100.36 (1.17%)
Current stock: JNJ
NVS $88.61 (0.81%)
Current stock: NVS
RHHBY $36.39 (1.51%)
Current stock: RHHBY